Drug intelligence / Profile preview

ozone (Premier Research Laboratories)

Development stage
Unknown
Lead developer
Yunus Burak Bayır
Modality
Small Molecules
Administration
Perineural Injection
01

Overview

Ozone (O3) is a triatomic form of oxygen used in medical therapy for its potent anti-inflammatory, analgesic, and immunomodulatory properties. In the context of carpal tunnel syndrome (CTS), medical ozone is typically administered via ultrasound-guided perineural injection into the space surrounding the median nerve. The mechanism of action involves the modulation of oxidative stress, inhibition of pro-inflammatory cytokines (such as TNF-alpha and IL-1beta), and enhancement of local microcirculation. This specific application is being investigated by Yunus Burak Bayır in a randomized, triple-blind clinical trial comparing the effectiveness of ozone injections against corticosteroids and 5% dextrose for the management of moderate CTS symptoms.

Brand names
Ozene
Other names
O3O-3O 3medical ozonetriatomic oxygen
02

Targets

KEAP1 (Kelch-like ECH-associated protein 1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on ozone (Premier Research Laboratories).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ozone (Premier Research Laboratories).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call